T C Kotsimbos
Overview
Explore the profile of T C Kotsimbos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van de Sandt C, Clemens E, Grant E, Rowntree L, Sant S, Halim H, et al.
Nat Commun
. 2019 Dec;
10(1):5579.
PMID: 31811120
Although influenza viruses lead to severe illness in high-risk populations, host genetic factors associated with severe disease are largely unknown. As the HLA-A*68:01 allele can be linked to severe pandemic...
2.
Rowntree L, Bayliss J, Nguyen T, Kotsimbos T, Mifsud N
Clin Exp Immunol
. 2013 Apr;
172(3):483-9.
PMID: 23600837
Microchimerism is the presence of foreign cells in an individual below 1% of total cells, which can occur in the setting of solid organ transplantation. This study quantitated donor-derived cellular...
3.
Bourdin A, Mifsud N, Chanez B, Chanez P, Snell G, Kotsimbos T
Am J Transplant
. 2013 Mar;
13(5):1370.
PMID: 23465090
No abstract available.
4.
Paraskeva M, Bailey M, Levvey B, Griffiths A, Kotsimbos T, Williams T, et al.
Am J Transplant
. 2011 Jul;
11(10):2190-6.
PMID: 21794087
Early studies reported cytomegalovirus (CMV) pneumonitis as a risk factor for development of bronchiolitis obliterans syndrome (BOS) following lung transplantation. While improvements in antiviral prophylaxis have resulted in a decreased...
5.
Young A, Wilson J, Kotsimbos T, Naughton M
Thorax
. 2007 Aug;
63(1):72-7.
PMID: 17675317
Background: The clinical benefits of domiciliary non-invasive positive pressure ventilation (NIV) have not been established in cystic fibrosis (CF). We studied the effects of nocturnal NIV on quality of life...
6.
Howden B, Michaelides A, Spelman D, Spencer A, Schwarer A, Wesselingh S, et al.
Bone Marrow Transplant
. 2003 Oct;
32(8):795-800.
PMID: 14520424
Cytomegalovirus viral load measurement is a powerful new tool for monitoring of CMV disease; however, the optimal strategy for use is unknown. Weekly plasma CMV viral loads and CMV-related outcomes...
7.
Michaelides A, Liolios L, Glare E, Spelman D, Bailey M, Walters E, et al.
Transplantation
. 2001 Jul;
72(1):141-7.
PMID: 11468549
Background: Human cytomegalovirus (HCMV) reactivation and disease remain relatively common in lung transplant recipients (LTR) despite the use of ganciclovir prophylaxis protocols for all HCMV at-risk patients. The specific aims...
8.
Wong J, Tait B, Levvey B, Griffiths A, Esmore D, Snell G, et al.
J Heart Lung Transplant
. 2001 Mar;
20(2):199.
PMID: 11250351
No abstract available.
9.
Snell G, Walters E, Kotsimbos T, Williams T
Med J Aust
. 2001 Mar;
174(3):137-40.
PMID: 11247617
Idiopathic pulmonary fibrosis (IPF) is an increasingly recognised, serious lung disease. A recent International Consensus Statement has redefined the term "idiopathic pulmonary fibrosis", restricting its use to the entity previously...
10.
Gabbay E, Walters E, Orsida B, Whitford H, Ward C, Kotsimbos T, et al.
Am J Respir Crit Care Med
. 2000 Dec;
162(6):2182-7.
PMID: 11112135
In conditions characterized by airway inflammation, exhaled nitric oxide (eNO) levels are increased. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by airway inflammation and development of progressive airway narrowing...